Global Knee Replacement Implants Market: International Catalysts and Concerns: Expected to Decline at a CAGR of -0.5% to approximately $7.8bn in 2024

December 9, 2020

Global Knee Replacement Implants Market shows Global sales of knee replacement implants totaled approximately $7.9bn in 2019. During the forecast period covered by this report, the market is expected to decline at a CAGR of -0.5% to approximately $7.8bn in 2024. View the report here.

This medical market and technology report provides a comprehensive discussion of the global market for knee replacement implants. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.

Although the market suffered a significant setback during the early days of the COVID-19 pandemic, it is expected to continue to improve over the forecast period due to new knee replacement patients seeking treatment and surgeons playing catch-up with the backlog of patients who have deferred treatment.

Growth in the knee replacement market is generally influenced by an aging global population and increasing life expectancy.

This report provides the following useful information:

  • osteoarthritis prevalence data
  • knee replacement procedure volumes
  • an overview of knee replacement implant technology
  • products offered by leading manufacturers
  • in-depth market and competitive analyses.

Key Topics Covered:

1. Clinical Overview and Procedure Volumes

1.1 Indications for knee arthroplasty

1.2 Epidemiology

1.3 Types of knee arthroplasty

1.3.1 Unicondylar knee arthroplasty

1.3.2 Revision knee arthroplasty

1.4 Procedure volumes

1.5 Bibliography

2. Knee Replacement Implants Market

2.1 Market analysis

2.1.1 US reimbursement issues

2.1.2 International catalysts and concerns

2.2 Competitive analysis

2.3 Product trends

2.3.1 Leading products

2.4 Bibliography

Appendix: Company Listing

Global Knee Replacement Implants Market view here.

 More reports here.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.